Products

Current Location£ºProducts in IDL Application

Ze 339£¨Petasites hybridus Tablets£©

The active ingredient is Petasites hybridus leaf native extract, CTA is in the progress of evaluation and approval by CFDA.

Petasites hybridus Tablets

Drug Name:

Petasites hybridus Tablets

Indication:

For the treatment of symptoms of allergic rhinitis (hay-fever) as well as related symptoms in eyes, nose and throat.

Registration Progress£º

Under evaluation.